Sickle Cell Hemoglobin with Mutation at αHis-50 Has Improved Solubility

Area of Science:

• Biochemistry
• Molecular Biology
• Hematology

Background:

• Sickle cell hemoglobin (Hb S) polymerizes in its deoxygenated state, leading to sickle cell disease.
• Understanding the molecular interactions governing Hb S polymerization is crucial for developing therapeutic strategies.

Purpose of the Study:

• To investigate the role of axial and lateral contacts in Hb S polymerization by creating novel recombinant mutants.
• To structurally and functionally characterize these mutants to elucidate their polymerization propensity.

Main Methods:

• Expression and purification of novel Hb S recombinants with specific amino acid substitutions in Escherichia coli.
• Structural analysis using (1)H NMR spectroscopy to assess changes in protein interfaces and heme pockets.
• Functional characterization including oxygen binding affinity, cooperativity, Bohr effect, and polymerization assays (dextran-Csat).

Main Results:

• Substitutions at αHis-20 or αHis-50 did not significantly alter subunit interfaces or heme pockets.
• Double mutants exhibited only minor structural changes in β-heme pockets.
• Most mutants showed similar functional properties to Hb S, except for rHb (βE6V/αH20R), which polymerized more readily.
• rHb (βE6V/αH20Q/αH50Q) demonstrated enhanced stability at elevated temperatures.

Conclusions:

• Specific amino acid substitutions can modulate Hb S polymerization, with rHb (βE6V/αH20R) being a key example of enhanced polymerization.
• Targeting axial and lateral contact sites offers potential for developing Hb S polymerization inhibitors.
• Further research into these mutants can provide deeper insights into the structural basis of sickle cell disease pathogenesis.